Last 12 months
Inside the activity.
0 purchase rows · 36 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 30 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 9, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 2,203 | Not disclosed Strike: $114.17 | Not disclosed |
DisclosureSEC source: 0000874716-26-000127 · wk-form4_1788987605.xml · derivative · entry 3 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,203 shares Expires 2026-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
SaleCommon Stock | 2,203 | $532.08 | $1,172,177.97 |
DisclosureSEC source: 0000874716-26-000127 · wk-form4_1788987605.xml · nonDerivative · entry 2 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionCommon Stock | 2,203 | $114.17 | $251,516.51 |
DisclosureSEC source: 0000874716-26-000127 · wk-form4_1788987605.xml · nonDerivative · entry 1 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:00 UTC |
Emerson AndrewEVP, CFO and Treasurer
|
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 265 | Not disclosed Strike: $178.26 | Not disclosed |
DisclosureSEC source: 0000874716-26-000125 · wk-form4_1787605205.xml · derivative · entry 3 Emerson Andrew · CIK 0002058587 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 925 Underlying: Common Stock · 265 shares Expires 2028-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable F2 · derivative.exercise_date: Grant of option to buy 1,190 shares of Issuer common stock that became exercisable in one installment on February 14, 2023. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:00 UTC |
Emerson AndrewEVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 86 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000125 · wk-form4_1787605205.xml · nonDerivative · entry 2 Emerson Andrew · CIK 0002058587 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,421.444 Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:00 UTC |
Emerson AndrewEVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 265 | $178.26 | $47,238.90 |
DisclosureSEC source: 0000874716-26-000125 · wk-form4_1787605205.xml · nonDerivative · entry 1 Emerson Andrew · CIK 0002058587 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,507.444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 20 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026 and June 30, 2026. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 21:00 UTC |
HOOLEY JOSEPH LDirector
|
GrantCommon Stock | 49 | $558.80 | $27,381.20 |
DisclosureSEC source: 0000874716-26-000117 · wk-form4_1785790805.xml · nonDerivative · entry 1 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325 F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the 'Plan') in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($27,280.22) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 21:00 UTC |
FENNELL GEORGEExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 639 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000114 · wk-form4_1780434004.xml · derivative · entry 3 FENNELL GEORGE · CIK 0001521861 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 639 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock and vested in one installment on June 1, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock and vested in one installment on June 1, 2026. F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock and vested in one installment on June 1, 2026. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 21:00 UTC |
FENNELL GEORGEExecutive Vice President
|
Tax withholdingCommon Stock | 284 | $566.79 | $160,968.36 |
DisclosureSEC source: 0000874716-26-000114 · wk-form4_1780434004.xml · nonDerivative · entry 2 FENNELL GEORGE · CIK 0001521861 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,433 Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 21:00 UTC |
FENNELL GEORGEExecutive Vice President
|
Exercise / conversionCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000114 · wk-form4_1780434004.xml · nonDerivative · entry 1 FENNELL GEORGE · CIK 0001521861 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:01 UTC |
Vandebroek Sophie V.Director
|
GrantRestricted Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000107 · wk-form4_1778792458.xml · derivative · entry 2 Vandebroek Sophie V. · CIK 0001442078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:01 UTC |
Vandebroek Sophie V.Director
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000107 · wk-form4_1778792458.xml · derivative · entry 1 Vandebroek Sophie V. · CIK 0001442078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
SAMAD SAMDirector
|
GrantDeferred Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000106 · wk-form4_1778792452.xml · derivative · entry 2 SAMAD SAM · CIK 0001694295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
SAMAD SAMDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000106 · wk-form4_1778792452.xml · derivative · entry 1 SAMAD SAM · CIK 0001694295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Peacock KarenDirector
|
GrantDeferred Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000105 · wk-form4_1778792446.xml · derivative · entry 2 Peacock Karen · CIK 0001786299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Peacock KarenDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000105 · wk-form4_1778792446.xml · derivative · entry 1 Peacock Karen · CIK 0001786299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
GrantRestricted Stock Unit · Derivative | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000104 · wk-form4_1778792440.xml · derivative · entry 4 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75 Underlying: Common Stock · 75 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · shares: Additional grant as Lead Director. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
GrantRestricted Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000104 · wk-form4_1778792440.xml · derivative · entry 3 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 168 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000104 · wk-form4_1778792440.xml · derivative · entry 2 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168 Underlying: Common Stock · 168 shares Expires 2036-05-11 F2 · shares: Additional grant as Lead Director. F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Kingsley Lawrence DDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000104 · wk-form4_1778792440.xml · derivative · entry 1 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
JUNIUS DANIEL MDirector
|
GrantRestricted Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000103 · wk-form4_1778792434.xml · derivative · entry 2 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
JUNIUS DANIEL MDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000103 · wk-form4_1778792434.xml · derivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
HOOLEY JOSEPH LDirector
|
GrantDeferred Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000102 · wk-form4_1778792428.xml · derivative · entry 2 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
HOOLEY JOSEPH LDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000102 · wk-form4_1778792428.xml · derivative · entry 1 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
ESSIG STUARTDirector
|
GrantRestricted Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000101 · wk-form4_1778792420.xml · derivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
ESSIG STUARTDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000101 · wk-form4_1778792420.xml · derivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Claflin Bruce L.Director
|
GrantDeferred Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000100 · wk-form4_1778792415.xml · derivative · entry 2 Claflin Bruce L. · CIK 0001403694 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Claflin Bruce L.Director
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000100 · wk-form4_1778792415.xml · derivative · entry 1 Claflin Bruce L. · CIK 0001403694 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Britt Irene ChangDirector
|
GrantDeferred Stock Unit · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000099 · wk-form4_1778792405.xml · derivative · entry 2 Britt Irene Chang · CIK 0001502314 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753 Underlying: Common Stock · 234 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:00 UTC |
Britt Irene ChangDirector
|
GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 525 | $0.00 Strike: $533.92 | $0.00 |
DisclosureSEC source: 0000874716-26-000099 · wk-form4_1778792405.xml · derivative · entry 1 Britt Irene Chang · CIK 0001502314 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 525 shares Expires 2036-05-11 F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:11 UTC |
Vandebroek Sophie V.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000088 · wk-form4_1778533863.xml · derivative · entry 3 Vandebroek Sophie V. · CIK 0001442078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:11 UTC |
Vandebroek Sophie V.Director
|
Exercise / conversionCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000088 · wk-form4_1778533863.xml · nonDerivative · entry 1 Vandebroek Sophie V. · CIK 0001442078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
SZOSTAK M ANNEDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000087 · wk-form4_1778533854.xml · derivative · entry 4 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F4 · price: Not applicable. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
SZOSTAK M ANNEDirector
|
Exercise / conversionCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000087 · wk-form4_1778533854.xml · nonDerivative · entry 1 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Peacock KarenDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000086 · wk-form4_1778533848.xml · derivative · entry 2 Peacock Karen · CIK 0001786299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Peacock KarenDirector
|
Exercise / conversionCommon Stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000086 · wk-form4_1778533848.xml · nonDerivative · entry 1 Peacock Karen · CIK 0001786299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000085 · wk-form4_1778533840.xml · derivative · entry 4 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000085 · wk-form4_1778533840.xml · derivative · entry 3 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionCommon Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000085 · wk-form4_1778533840.xml · nonDerivative · entry 2 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
Kingsley Lawrence DDirector
|
Exercise / conversionCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000085 · wk-form4_1778533840.xml · nonDerivative · entry 1 Kingsley Lawrence D · CIK 0001301427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
JUNIUS DANIEL MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000084 · wk-form4_1778533834.xml · derivative · entry 2 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
JUNIUS DANIEL MDirector
|
Exercise / conversionCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000084 · wk-form4_1778533834.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
HOOLEY JOSEPH LDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000874716-26-000083 · wk-form4_1778533828.xml · derivative · entry 2 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 158 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F2 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:10 UTC |
HOOLEY JOSEPH LDirector
|
Exercise / conversionCommon Stock | 158 | $0.00 | $0.00 |
DisclosureSEC source: 0000874716-26-000083 · wk-form4_1778533828.xml · nonDerivative · entry 1 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed May 4, 2026 21:00 UTC |
HOOLEY JOSEPH LDirector
|
GrantCommon Stock | 43 | $560.80 | $24,114.40 |
DisclosureSEC source: 0000874716-26-000069 · wk-form4_1777928406.xml · nonDerivative · entry 1 HOOLEY JOSEPH L · CIK 0001123847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118 F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($24,375.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:01 UTC |
Underberg Sharon E.EVP, GC & Corporate Secretary
|
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 197 | Not disclosed Strike: $505.53 | Not disclosed |
DisclosureSEC source: 0000874716-26-000050 · wk-form4_1772748092.xml · derivative · entry 2 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197 shares Expires 2032-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vested on February 14, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:01 UTC |
Underberg Sharon E.EVP, GC & Corporate Secretary
|
Exercise / conversionCommon Stock | 197 | $505.53 | $99,589.41 |
DisclosureSEC source: 0000874716-26-000050 · wk-form4_1772748092.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,137.654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:01 UTC |
Hunt NimrataExecutive Vice President
|
SaleCommon Stock | 1,758 | $634.57 | $1,115,577.22 |
DisclosureSEC source: 0000874716-26-000049 · wk-form4_1772748086.xml · nonDerivative · entry 1 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,140.944 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $634.5301 to a high of $634.8201 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:00 UTC |
MAZELSKY JONATHAN JAYDirector · President and CEO
|
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 197 | $0.00 Strike: $505.53 | $0.00 |
DisclosureSEC source: 0000874716-26-000043 · wk-form4_1772488807.xml · derivative · entry 17 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197 shares Expires 2032-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that vested on February 14, 2026. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:00 UTC |
MAZELSKY JONATHAN JAYDirector · President and CEO
|
Exercise / conversionCommon Stock | 197 | $505.53 | $99,589.41 |
DisclosureSEC source: 0000874716-26-000043 · wk-form4_1772488807.xml · nonDerivative · entry 15 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,803.302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.